INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $68,000 | +4.6% | 10,111 | -10.2% | 0.00% | 0.0% |
Q3 2015 | $65,000 | -31.6% | 11,258 | -3.3% | 0.00% | -25.0% |
Q2 2015 | $95,000 | -21.5% | 11,646 | -21.4% | 0.00% | 0.0% |
Q1 2015 | $121,000 | -12.9% | 14,826 | -2.1% | 0.00% | 0.0% |
Q4 2014 | $139,000 | – | 15,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |